Table 1.
Phosphorylation Site | Kinases/Signaling Pathways | Reported Effects | References |
---|---|---|---|
Threonine 654 | CaMKII | N.D. 1 | [55] |
ROCK2 | Blocking T654 phosphorylation; promoting BACE1 relocation from endosomes to lysosomes and APP trafficking to lysosomes; reducing Aβ generation when inhibited | [56] | |
Serine 655 | PKC, CaMKII | Increasing the secretion of APP into cerebrospinal fluid and decreasing the cleavage of mature APP; enhancing APP secretory traffic when activated | [55,57,58,59] |
ROCK1 | Enhancing the interaction between BACE1 and APP and promoting Aβ generation when activated | [60] | |
APP kinase I | Putatively modulating the internalization of APP when activated | [61] | |
Threonine 668 | CDC2 kinase | Increasing the content of immature APP and C-terminal fragments while reducing the level of secreted APP products when activated | [40] |
CDK5 | Enhancing the secretion of Aβ, sAPPβ, and sAPPα; enriching APP in endosomes when activated | [43,44,49] | |
GSK-3β | Affecting copper-induced APP trafficking to axons | [41,42] | |
JNK | Inducing APP degradation, lowering sAPPβ and Aβ generation, and promoting non-amyloidogenic processing when inhibited | [46,51,52] | |
JIP-3-JNK | Phosphorylating APP and transporting pAPP to neuritis when activated | [50] | |
DAPK1 | Shifting APP toward non-amyloidogenic pathway and decreasing Aβ generation when inhibited | [54,62] | |
LRRK2 | Elevating the nuclear translocation of AICD and its transcriptional activity and exacerbating dopaminergic neurons when activated | [63] | |
Plk2 | Accelerating APP amyloidogenic cleavage by β-secretase at synapses when activated | [64] | |
Serine 675 | Plk2 | Stimulating the endocytosis of APP and driving the BACE1 cleavage; promoting meprin β mediated APP processing when activated | [64] |
Tyrosine 682 | Abl | Phosphorylating APP and forming stable complexes with pAPP; affecting APP binding to FE65 and X11 when activated | [65] |
Src | Increasing the formation of pAPP-Grb2 complexes when activated | [66] | |
NGF-TrkA | Reducing the generation of the AICD; regulating the subcellular distribution and activation of TrkA when activated | [67,68] | |
Fyn | Affecting the correct APP trafficking and sorting in neurons and the binding with clathrin and AP2 when activated | [69] | |
Tyrosine 687 | Tyrosine kinase | Retaining APP in ER and TGN and decreasing its turnover rate; reducing Aβ formation when activated | [70,71] |
Tyrosine 653 | N.D. | N.D. | [38] |
Threonine 686 | N.D. | N.D. | [38] |
Serine 198 and serine 206 | CK-1 and CK-2-like ectoprotein kinases | Essential for the correct location of APP on the cell surface | [72,73] |
Abbreviations: 1 N.D: not defined in the literature; CaMKII: Ca2+/calmodulin-dependent protein kinase II; ROCK2: Rho-associated coiled-coil kinase 2; BACE1: β-site APP-cleaving enzyme 1; APP: amyloid precursor protein; Aβ: amyloid-β; PKC: protein kinase C; ROCK1: Rho-associated coiled-coil kinase 1; CDC2: p34cdc2 protein kinase; CDK5: cyclin-dependent kinase 5; sAPPβ; soluble APPβ; sAPPα: soluble APPα; GSK-3β: glycogen synthesis kinase-3β; JNK: c-Jun N-terminal kinase; JIP-3: JNK-interacting protein 3; DAPK1: death-associated protein kinase 1; LRRK2: leucine-rich repeat kinase 2; AICD: APP intracellular domain; NGF: nerve growth factor; ER: endoplasmic reticulum; TGN: trans-Golgi network; CK: casein kinase.